Stephen Hahn, AP
August 27, 2020 06:52 AM EDTUpdated 10:20 AM
Bioregnum
Coronavirus
Opinion

FDA com­mish Hahn spot­lights Oct 22 vac­cine ad­vi­so­ry meet­ing as the next big flash­point in the Covid-19 cam­paign

John Carroll

Editor & Founder

Mark Oc­to­ber 22 on your cal­en­dars if you want to watch the next big con­tro­ver­sy over the rapid-fire de­vel­op­ment of Covid-19 vac­cines play out at …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

A service from the Financial Times